A
Accelerant Holdings
ARXCIK 0001997350NYSEEmerging GrowthInsurance Agents, Brokers & ServiceE9CAFY ends Dec 31
Period
FY 2025
Revenue
$912.90M
Net Income
$-1.35B
Total Assets
$8.26B
Equity
$697.70M
Shares Out
166.19M
Op. Cash Flow
$445.10M
Business
Accelerant Holdings is a foreign private issuer in Insurance Agents, Brokers & Service, headquartered in Canada. Shares trade on NYSE under the ticker ARX.
Auto-generated from company profile
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Ceding commission income | 357 | 250 | 164 | |
| Direct commission income | 162 | 67 | 38 | |
| Net earned premiums | 298 | 227 | 105 | |
| Net investment income | 49 | 39 | 19 | |
| Net realized gains on investments | 8 | 2 | 500,000 | |
| Net unrealized gains on investments | 39 | 19 | 17 | |
| Total revenues | 913 | 603 | 344 | |
| Losses and loss adjustment expenses | 204 | 167 | 80 | |
| Amortization of deferred acquisition costs | 80 | 81 | 50 | |
| General and administrative expenses | 400 | 249 | 183 | |
| Interest expenses | 11 | 12 | 11 | |
| Depreciation and amortization | 35 | 27 | 15 | |
| Profits interest distribution expenses | 1,380 | 0 | 0 | |
| Net foreign exchange losses (gains) | 20 | −5 | 4 | |
| Other expenses | 104 | 39 | 46 | |
| Total expenses | 2,235 | 571 | 388 | |
| Loss before income taxes | −1,322 | 32 | −44 | |
| Income tax expense | −23 | −9 | −20 | |
| Net (loss) income | −1,345 | 23 | −64 | |
| Adjustment for net (income) loss attributable to non-controlling interests | −9 | 4 | 15 | |
| Deemed dividend upon redemption of Class C preference shares | −71 | 0 | 0 | |
| Net income attributable to Accelerant common shareholders, diluted | −1,425 | 27 | −49 | |
| Net income attributable to Accelerant common shareholders, basic | −1,425 | 27 | −49 | |
| Basic (in usd per share) | −7.49 | 0.16 | −0.29 | |
| Diluted (in usd per share) | −7.49 | 0.14 | −0.29 | |
| Weighted-average common shares outstanding - basic (in shares) | 190 | 166 | 166 | |
| Weighted-average common shares outstanding - diluted | 190 | 200 | 166 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Available for sale investments, at fair value | 712 | 544 | — | — | |
| Equity method investments | 10 | 18 | — | — | |
| Other investments | 84 | 45 | — | — | |
| Total investments | 806 | 608 | — | — | |
| Cash, cash equivalents and restricted cash | 1,799 | 1,273 | 775 | 484 | |
| Premiums receivable (net of allowance 2025: $4.6 and 2024: $2.4) | 1,078 | 792 | — | — | |
| Ceded unearned premiums | 1,812 | 1,558 | — | — | |
| Total reinsurance recoverables on unpaid losses and LAE | 1,682 | 1,070 | 606 | 333 | |
| Other reinsurance recoverables | 594 | 364 | — | — | |
| Deferred acquisition costs | 77 | 61 | 53 | 27 | |
| Goodwill and other intangible assets, net | 115 | 64 | — | — | |
| Capitalized technology development costs, net | 101 | 84 | 69 | 44 | |
| Other assets | 198 | 222 | — | — | |
| Total assets | 8,263 | 6,095 | — | — | |
| Total unpaid losses and LAE | 2,005 | 1,294 | 773 | 415 | |
| Unearned premiums | 2,163 | 1,803 | — | — | |
| Payables to reinsurers | 1,221 | 1,109 | — | — | |
| Deferred ceding commissions | 233 | 193 | 120 | 85 | |
| Funds held under reinsurance | 1,200 | 747 | — | — | |
| Debt | 121 | 121 | — | — | |
| Accounts payable and other liabilities | 594 | 400 | — | — | |
| Total liabilities | 7,537 | 5,668 | — | — | |
| Commitments and contingencies (Note 19) | — | — | — | — | |
| Class C convertible preference shares (issued and outstanding 2024: 5,556,546) | 0 | 104 | 0 | 0 | |
| Common shares (par value $0.000001 per share, issued and outstanding 2025: Class A - 114,580,918; Class B - 107,241,428 and 2024: 166,185,094) | 0 | 0 | — | — | |
| Additional paid-in capital | 2,232 | 125 | — | — | |
| Accumulated other comprehensive income (loss) | 2 | −20 | — | — | |
| Accumulated deficit | −1,537 | −183 | — | — | |
| Total Accelerant shareholders' equity | 698 | 304 | — | — | |
| Non-controlling interests | 29 | 18 | — | — | |
| Total equity | 726 | 427 | 287 | 350 | |
| Total liabilities and equity | 8,263 | 6,095 | — | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Earnings from equity method investments | −2 | −2 | −3 | |
| Share-based compensation expenses | 43 | 8 | 5 | |
| Deferred income tax (benefit) expense | −32 | −41 | 300,000 | |
| Net gain on commutation | 0 | 0 | −5 | |
| Net accretion of discount on fixed maturity securities and short-term investments | −8 | −6 | −500,000 | |
| Other, net | 3 | 2 | 800,000 | |
| Premiums receivable | −259 | −319 | −222 | |
| Ceded unearned premiums | −226 | −648 | −286 | |
| Reinsurance recoverables on unpaid losses and LAE | −589 | −471 | −253 | |
| Other reinsurance recoverables | −219 | 8 | −162 | |
| Deferred acquisition costs | −16 | −8 | −19 | |
| Unpaid losses and loss adjustment expenses | 645 | 540 | 327 | |
| Unearned premiums | 287 | 675 | 377 | |
| Payables to reinsurers | 87 | 636 | 215 | |
| Deferred ceding commissions | 56 | 68 | 33 | |
| Funds held under reinsurance | 451 | 203 | 303 | |
| Other assets, accounts payable and other liabilities | 180 | 117 | 43 | |
| Net cash provided by operating activities | 445 | 786 | 290 | |
| Equity securities | 0 | 115 | 89 | |
| Fixed maturity securities | 306 | 84 | 42 | |
| Equity method investments | 1 | 0 | — | |
| Other investments | 4 | 300,000 | 0 | |
| Maturities of fixed maturity securities | 50 | 19 | 11 | |
| Equity securities | 0 | 0 | −47 | |
| Fixed maturity securities | −509 | −501 | −74 | |
| Equity method investments | −2 | −4 | −900,000 | |
| Net change in short-term investments | 29 | −57 | −700,000 | |
| Purchases of subsidiaries, net of cash acquired | −10 | −500,000 | 3 | |
| Capitalized technology development expenditures | −41 | −34 | −33 | |
| Other, net | −500,000 | −2 | −1 | |
| Net cash used in investing activities | −174 | −380 | −13 | |
| Issuance of common shares, net of issuance costs | 392 | 0 | 0 | |
| Redemption of Class C convertible preference shares | −175 | 0 | — | |
| Issuance of convertible preference shares, net of issuance costs | 0 | 115 | 700,000 | |
| Credit facility borrowings | 5 | 0 | 0 | |
| Credit facility repayment | −5 | 0 | 0 | |
| Issuance of debt, net of issuance costs | 0 | 50 | 20 | |
| Payment of debt | −800,000 | −50 | −2 | |
| Acquisition of non-controlling interests in subsidiaries | −2 | 0 | −6 | |
| Dividends paid to non-controlling interests | −8 | −4 | −3 | |
| Net cash provided by financing activities | 206 | 110 | 10 | |
| Net increase in cash, cash equivalents and restricted cash | 477 | 516 | 288 | |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 49 | −18 | 4 | |
| Interest on debt paid | 10 | 11 | 10 | |
| Income taxes paid | 59 | 46 | 20 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro